US EditionPublished • loading... • Updated
ARS Pharmaceuticals Sues AptarGroup Over Alleged Monopoly in Epinephrine Device Supply
Summary by jdjournal.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
ARS Pharmaceuticals Sues AptarGroup Over Alleged Monopoly in Epinephrine Device Supply
San Diego-based ARS Pharmaceuticals, the biotech company behind the FDA-approved epinephrine nasal spray neffy, has filed an antitrust lawsuit against packaging giant AptarGroup Inc., alleging the company has unlawfully monopolized the supply of critical device components. The case, filed in the U.S. District Court for the Southern District of California, could have sweeping implications for both the pharmaceutical device supply chain and the ac…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
